Remote limb ischemic postconditioning promotes motor function recovery in a rat model of ischemic stroke via the up‐regulation of endogenous tissue kallikrein

Autor: Dan Liang, Ce Li, Zheng Wang, Junfa Wu, Bei-Yao Gao, Yulong Bai, Xi-Biao He
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
medicine.medical_specialty
medicine.drug_class
Ischemia
Endogeny
Bradykinin
Neuroprotection
Rats
Sprague-Dawley

03 medical and health sciences
symbols.namesake
0302 clinical medicine
Physiology (medical)
Internal medicine
Lectins
Occlusion
medicine
Animals
Pharmacology (medical)
Ischemic Postconditioning
Postural Balance
Pharmacology
Cardioprotection
Movement Disorders
business.industry
Anti-Inflammatory Agents
Non-Steroidal

Infarction
Middle Cerebral Artery

Original Articles
Recovery of Function
Receptor antagonist
medicine.disease
Magnetic Resonance Imaging
Rats
Up-Regulation
Psychiatry and Mental health
Disease Models
Animal

030104 developmental biology
Cardiology
Nissl body
symbols
business
Microtubule-Associated Proteins
Tissue Kallikreins
030217 neurology & neurosurgery
Immunostaining
Popis: Aims Remote ischemic conditionings, such as pre- and per-conditioning, are known to provide cardioprotection in animal models of ischemia. However, little is known about the neuroprotection effect of postconditioning after cerebral ischemia. In this study, we aim to evaluate the motor function rescuing effect of remote limb ischemic postconditioning (RIPostC) in a rat model of acute cerebral stroke. Methods Left middle cerebral artery occlusion (MCAO) was performed to generate the rat model of ischemic stroke, followed by daily RIPostC treatment for maximum 21 days. The motor function after RIPostC was assessed with foot fault test and balance beam test. Local infarct volume was measured through MRI scanning. Neuronal status was evaluated with Nissl's, HE, and MAP2 immunostaining. Lectin immunostaining was performed to evaluate the microvessel density and area. Results Daily RIPostC for more than 21 days promoted motor function recovery and provided long-lasting neuroprotection after MCAO. Reduced infarct volume, rescued neuronal loss, and enhanced microvessel density and size in the injured areas were observed. In addition, the RIPostC effect was associated with the up-regulation of endogenous tissue kallikrein (TK) level in circulating blood and local ischemic brain regions. A TK receptor antagonist HOE-140 partially reversed RIPostC-induced improvements, indicating the specificity of endogenous TK mediating the neuroprotection effect of RIPostC. Conclusion Our study demonstrates RIPostC treatment as an effective rehabilitation therapy to provide motor function recovery and alleviate brain impairment in a rat model of acute cerebral ischemia. We also for the first time provide evidence showing that the up-regulation of endogenous TK from remote conditioning regions underlies the observed effects of RIPostC.
Databáze: OpenAIRE